FI964815A - Piperatsiinijohdoksia 5-HT1A antagonisteina - Google Patents

Piperatsiinijohdoksia 5-HT1A antagonisteina Download PDF

Info

Publication number
FI964815A
FI964815A FI964815A FI964815A FI964815A FI 964815 A FI964815 A FI 964815A FI 964815 A FI964815 A FI 964815A FI 964815 A FI964815 A FI 964815A FI 964815 A FI964815 A FI 964815A
Authority
FI
Finland
Prior art keywords
piperazine derivatives
ht1a antagonists
hydrogen
compounds
ht1a
Prior art date
Application number
FI964815A
Other languages
English (en)
Swedish (sv)
Other versions
FI114985B (fi
FI964815A0 (fi
Inventor
Christopher Ian Brightwell
Michael Gerard Kelly
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of FI964815A0 publication Critical patent/FI964815A0/fi
Publication of FI964815A publication Critical patent/FI964815A/fi
Application granted granted Critical
Publication of FI114985B publication Critical patent/FI114985B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
FI964815A 1994-06-03 1996-12-02 Piperatsiinijohdoksia 5-HT1A antagonisteina FI114985B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9411099A GB9411099D0 (en) 1994-06-03 1994-06-03 Piperazine derivatives
GB9411099 1994-06-03
GB9501263 1995-01-23
PCT/GB1995/001263 WO1995033743A1 (en) 1994-06-03 1995-06-01 Piperazine derivatives as 5ht1a antagonists

Publications (3)

Publication Number Publication Date
FI964815A0 FI964815A0 (fi) 1996-12-02
FI964815A true FI964815A (fi) 1996-12-02
FI114985B FI114985B (fi) 2005-02-15

Family

ID=10756114

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964815A FI114985B (fi) 1994-06-03 1996-12-02 Piperatsiinijohdoksia 5-HT1A antagonisteina

Country Status (25)

Country Link
US (1) US5723464A (fi)
EP (1) EP0763031B1 (fi)
JP (1) JPH10500989A (fi)
KR (1) KR100359393B1 (fi)
CN (2) CN1048985C (fi)
AT (1) ATE192744T1 (fi)
AU (1) AU680147B2 (fi)
BR (1) BR9507910A (fi)
CA (1) CA2191871C (fi)
CZ (1) CZ287381B6 (fi)
DE (1) DE69516867T2 (fi)
DK (1) DK0763031T3 (fi)
ES (1) ES2145275T3 (fi)
FI (1) FI114985B (fi)
GB (1) GB9411099D0 (fi)
GR (1) GR3033449T3 (fi)
HU (1) HUT76466A (fi)
IL (1) IL113967A (fi)
MX (1) MX9605915A (fi)
NZ (2) NZ331452A (fi)
PT (1) PT763031E (fi)
RU (1) RU2165933C2 (fi)
SK (1) SK281418B6 (fi)
WO (1) WO1995033743A1 (fi)
ZA (1) ZA954525B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101722A (en) * 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
AU2622595A (en) * 1994-06-03 1996-01-04 John Wyeth & Brother Limited Novel processes and intermediates for the preparation of piperazine derivatives
EP0773942A1 (en) * 1994-07-26 1997-05-21 Pfizer Inc. 4-indole derivatives as serotonin agonists and antagonists
US5486518A (en) * 1995-04-10 1996-01-23 American Home Products Corporation 4-indolylpiperazinyl derivatives
US5519025A (en) * 1995-04-10 1996-05-21 American Home Products Corporation 4-indolylpiperazinyl derivatives
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
IT1282705B1 (it) * 1996-02-28 1998-03-31 Recordati Chem Pharm Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
DE19615232A1 (de) * 1996-04-18 1997-10-23 Merck Patent Gmbh Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
DE19725664A1 (de) * 1997-06-18 1998-12-24 Merck Patent Gmbh 3-Benzylpiperidine
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
JP2001512110A (ja) * 1997-08-01 2001-08-21 レコルダチ エッセ.ア.,ケミカル アンド ファーマシューティカル カンパニー 1,4−ジ置換ピペラジン
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
US6271234B1 (en) 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
CA2334254A1 (en) * 1998-06-15 1999-12-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US20060287335A1 (en) 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
EP1367053A4 (en) * 2001-02-27 2005-08-03 Kaneka Corp PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE N-ARYL-1-AMINO-2-PROPANOL DERIVATIVES
AU2003220110B2 (en) 2002-03-12 2009-04-09 Wyeth Process for making chiral 1,4-disubstituted piperazines
US7091349B2 (en) 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
CN1304388C (zh) * 2002-03-12 2007-03-14 惠氏公司 合成手性n-芳基哌嗪的方法
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
BR0308315A (pt) * 2002-03-12 2004-12-28 Wyeth Corp Preparação de ácido n1-(2'-piridil)-1,2-propanodiamina sulfâmico e seu uso na sìntese de piperazinas biologicamente ativas
CN100436448C (zh) * 2003-06-11 2008-11-26 惠氏公司 二环吲哚基衍生物以及其作为5-羟色胺能活性剂的应用
US7179813B2 (en) 2003-06-11 2007-02-20 Wyeth Bicyclic indolyl derivatives and methods for their use as serotonergic agents
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
MX2008015445A (es) * 2006-06-09 2008-12-12 Wyeth Corp Metodo para mejorar la funcion cognoscitiva.
EP3151820A4 (en) 2014-06-06 2017-11-22 Flexus Biosciences, Inc. Immunoregulatory agents
EA201790806A1 (ru) 2014-11-05 2017-11-30 Флексус Байосайенсиз, Инк. Иммунорегулирующие средства
UY36390A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
AR102537A1 (es) 2014-11-05 2017-03-08 Flexus Biosciences Inc Agentes inmunomoduladores

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
ATE179973T1 (de) * 1989-04-22 1999-05-15 Wyeth John & Brother Ltd Piperazin-derivate
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
IL101722A (en) * 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
SK281418B6 (sk) 2001-03-12
FI114985B (fi) 2005-02-15
ZA954525B (en) 1996-12-02
FI964815A0 (fi) 1996-12-02
CN1048985C (zh) 2000-02-02
JPH10500989A (ja) 1998-01-27
CN1227841A (zh) 1999-09-08
CZ287381B6 (en) 2000-11-15
GB9411099D0 (en) 1994-07-27
SK154196A3 (en) 1997-08-06
WO1995033743A1 (en) 1995-12-14
MX9605915A (es) 1997-12-31
CN1149873A (zh) 1997-05-14
CZ350796A3 (en) 1997-06-11
HU9603315D0 (en) 1997-01-28
NZ331452A (en) 2000-01-28
ES2145275T3 (es) 2000-07-01
US5723464A (en) 1998-03-03
PT763031E (pt) 2000-10-31
KR100359393B1 (ko) 2003-01-24
DE69516867D1 (de) 2000-06-15
EP0763031A1 (en) 1997-03-19
DE69516867T2 (de) 2000-11-02
RU2165933C2 (ru) 2001-04-27
ATE192744T1 (de) 2000-05-15
IL113967A0 (en) 1995-10-31
NZ287498A (en) 1998-10-28
CN1093122C (zh) 2002-10-23
HUT76466A (en) 1997-09-29
GR3033449T3 (en) 2000-09-29
CA2191871C (en) 2004-09-21
BR9507910A (pt) 1997-08-12
CA2191871A1 (en) 1995-12-14
IL113967A (en) 1999-03-12
EP0763031B1 (en) 2000-05-10
AU680147B2 (en) 1997-07-17
KR970703333A (ko) 1997-07-03
AU2623095A (en) 1996-01-04
DK0763031T3 (da) 2000-08-14

Similar Documents

Publication Publication Date Title
FI964815A (fi) Piperatsiinijohdoksia 5-HT1A antagonisteina
AP2002002637A0 (en) Novel piperazine
CO5271691A1 (es) Nuevos compuestos
DK0775129T3 (da) 3-Benzoylbenzofuranderivater som thyroidhormonantagonister
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
JO2321B1 (en) 4-phenyl-pyridine derivatives
ATE316962T1 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
MX9800483A (es) Derivados de piperazina y su uso como antagonistas de 5-ht1a.
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
ES8602723A1 (es) Un procedimiento para la preparacion de nuevas n-bencil-propilaminas sustituidas.
PT1049670E (pt) Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc
ES2148745T3 (es) Derivados de piperidina usados como diureticos.
GB0119396D0 (en) Hydroxamic acid derivatives

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114985

Country of ref document: FI